PUT/PFIZER INC/30/0.1/17.01.25 | Real-time BOERSE MUENCHEN 09:26:49 01/07/2024 BST | ||
| 0.306 EUR | +0.66% |
|
| 1 month | +2.70% | ||
| 3 months | -16.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 01/07/24 | 0.306 | +0.66% |
| 28/06/24 | 0.304 | -8.98% |
| 27/06/24 | 0.334 | -1.47% |
| 26/06/24 | 0.339 | +11.15% |
| 25/06/24 | 0.305 | +6.64% |
Real-time BOERSE MUENCHEN
Last update July 01, 2024 at 09:26 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Goldman Sachs |
| WKN | GQ4D8V |
| ISIN | DE000GQ4D8V9 |
| Date issued | 04/09/2023 |
| Strike | 30 $ |
| Maturity | 17/01/2025 (201 Days) |
| Parity | 10 : 1 |
| Emission price | 0.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.532 € |
|---|---|
| Lowest since issue | 0.156 € |
| Spread | 0.01 € |
| Spread % | 3.23% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98
USD
Average target price
31.92
USD
Spread / Average Target
+14.07%
- Stock Market
- Warrants
- Warrant
